FDA.reportPublic FDA data

ALCAFTADINE Pharmacologic Class Indexing

Class set ID
e8ae259b-ba2a-42bb-bed6-711f6e840a84
Version
2
Effective date
20180813
Type
Indexing - Pharmacologic Class

Mapped DailyMed Labels#

Label, Manufacturer, Effective table
LabelManufacturerEffectiveSPL version
.Alembic Pharmaceuticals Inc. | Gland Pharma Limited202410073
Alcaftadine Ophthalmic Solution 0.25%Gland Pharma Limited202403053
d550d462-ab7c-4703-9e6d-3b2360abac7dAurohealth LLC | Eugia Pharma Specialities Limited202306231
LASTACAFT ® Antihistamine Eye Drops Drug FactsAllergan, Inc.202208104
These highlights do not include all the information needed to use LASTACAFT ® safely and effectively. See full prescribing information for LASTACAFT ® . LASTACAFT ® (alcaftadine ophthalmic solution) , f or t opical o phthalmic u se Initial U.S. Approval: 2010Allergan, Inc.2020060121
These highlights do not include all the information needed to use LASTACAFT ® safely and effectively. See full prescribing information for LASTACAFT ® . LASTACAFT ® (alcaftadine ophthalmic solution) 0.25% Initial U.S. Approval: 2010Rebel Distributors Corp | PSS World Medical, Inc. | STAT RX USA LLC | Dispensing Solutions, Inc. | SCRIPT PAK | Keltman Pharmaceuticals, Inc. | Rebel Distirbutors Corp.201209051
These highlights do not include all the information needed to use LASTACAFT™ safely and effectively. See full prescribing information for LASTACAFT™. LASTACAFT™ (alcaftadine ophthalmic solution) 0.25% Initial U.S. Approval: 2010Physicians Total Care, Inc.201009301